Table II.
Correlation between EGR-1 expression and clinicopathological features.
| EGR-1− n=6 | EGR-1+ n=13 | P-value | |
|---|---|---|---|
| Age (mean ± SD) | 45.3±19.6 | 64.6±10.8 | 0.062 |
| Gender (M:F) | 3:3 | 7:6 | 0.999 |
| Positive H. pylori | 3 (50.0%) | 6 (46.2%) | 0.999 |
| Location of specimen | 0.459 | ||
| Lower 1/3 | 5 (83.3%) | 7 (53.8%) | |
| Mid 1/3 | 0 (0%) | 4 (30.8%) | |
| Upper 1/3 | 1 (16.7%) | 2 (15.4%) | |
| Pathology | 0.001 | ||
| Chronic gastritis | 6 (100%) | 0 (0%) | |
| LGD | 0 (0%) | 6 (46.2%) | |
| HGD | 0 (0%) | 4 (30.8%) | |
| T1 ADC | 0 (0%) | 3 (23.1%) |
EGR-1, early growth response gene-1; SD, standard deviation; H. pylori, Helicobacter pylori; LGD, low-grade dysplasia; HGD, high-grade dysplasia; T1 ADC, T1 adenocarcinoma.